- Home
- LVRO vs KROS Comparison
LVRO vs KROS Comparison
Compare LVRO & KROS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LVRO
- KROS
- Stock Information
- Founded
- LVRO 2017
- KROS 2015
- Country
- LVRO Brazil
- KROS United States
- Employees
- LVRO N/A
- KROS N/A
- Industry
- LVRO Blank Checks
- KROS Biotechnology: Pharmaceutical Preparations
- Sector
- LVRO Finance
- KROS Health Care
- Exchange
- LVRO Nasdaq
- KROS Nasdaq
- Market Cap
- LVRO 149.0M
- KROS 565.0M
- IPO Year
- LVRO N/A
- KROS 2020
- Fundamental
- Price
- LVRO $1.59
- KROS $16.01
- Analyst Decision
- LVRO Sell
- KROS Buy
- Analyst Count
- LVRO 3
- KROS 14
- Target Price
- LVRO $1.88
- KROS $20.56
- AVG Volume (30 Days)
- LVRO 188.4K
- KROS 412.4K
- Earning Date
- LVRO 10-30-2025
- KROS 11-05-2025
- Dividend Yield
- LVRO N/A
- KROS N/A
- EPS Growth
- LVRO N/A
- KROS N/A
- EPS
- LVRO N/A
- KROS 0.47
- Revenue
- LVRO $1,667,345,189.00
- KROS $232,844,000.00
- Revenue This Year
- LVRO N/A
- KROS $5,998.31
- Revenue Next Year
- LVRO $11.45
- KROS N/A
- P/E Ratio
- LVRO N/A
- KROS $33.74
- Revenue Growth
- LVRO N/A
- KROS 85820.30
- 52 Week Low
- LVRO $1.25
- KROS $9.12
- 52 Week High
- LVRO $5.60
- KROS $72.37
- Technical
- Relative Strength Index (RSI)
- LVRO 48.44
- KROS 62.29
- Support Level
- LVRO $1.27
- KROS $15.34
- Resistance Level
- LVRO $2.75
- KROS $16.11
- Average True Range (ATR)
- LVRO 0.22
- KROS 0.44
- MACD
- LVRO 0.05
- KROS -0.01
- Stochastic Oscillator
- LVRO 22.33
- KROS 91.59
About LVRO Lavoro Limited
Lavoro Ltd operates in the agricultural inputs retail market, with operations spread across Brazil and Colombia, and an emergent agricultural input trading company in Uruguay. The reportable segments of the company include the Brazil Ag Retail, which comprises companies dedicated to the distribution of agricultural inputs such as crop protection, seeds, fertilizers and specialty products, in Brazil; Latam Ag Retail, which includes companies dedicated to the distribution of agricultural inputs outside Brazil (predominantly in Colombia); and the Crop Care. A substantial part of the company's overall revenue is generated from its Brazil Ag Retail segment.
About KROS Keros Therapeutics Inc.
Keros Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from hematological, pulmonary, and cardiovascular disorders with high unmet medical needs. The company's protein therapeutic product candidate, KER-050, is being developed for the treatment of low blood cells counts, or cytopenias, including anemia and thrombocytopenia, in patients with myelodysplastic syndromes, or MDS, and in patients with myelofibrosis.